News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Deals
Merck & Co., Inc. Says Schering-Plough Corporation Integration is On Track; to Seek U.S. Approvals of Five New Drugs in 2010
May 11, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
AP -- Drugmaker Merck & Co. said Tuesday that its integration of Schering Plough Corp. is off to a good start, with sales and other operations already combined in the top 20 companies where they operate.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
Merck & Co.
MORE ON THIS TOPIC
Podcast
CAR T Expands, M&A Ticks Up, Two Psychedelics Read Out, and the Supreme Court Rules on PrEP
July 2, 2025
·
1 min read
·
Heather McKenzie
Mergers & acquisitions
AbbVie Plunks Down $2.1B for Capstan and Its Novel CAR T Therapies
June 30, 2025
·
2 min read
·
Dan Samorodnitsky
Alzheimer’s disease
Alzheimer’s Deals Surged 780% After Leqembi, Kisunla Broke Approval Stalemate
June 30, 2025
·
2 min read
·
Annalee Armstrong
Layoffs
Sage Sacks Entire Staff After Supernus Buyout
June 30, 2025
·
1 min read
·
Tristan Manalac